Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $512.0900 (2.28%) ($488.0000 - $514.1100) on Wed. Apr. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 54 | Latest Price | $512.0900(2.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 5.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) IVW(37%) IWF(36%) QQQ(36%) | Factors Impacting REGN price | REGN will decline at least -1.84% in a week (0% probabilities). VIXM(-19%) VXX(-8%) UUP(-5%) TBT(-5%) IYT(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $501.83(2.04%) | 10 Day Moving Average | $488.04(4.93%) | 20 Day Moving Average | $473.68(8.11%) | To recent high | 0% | To recent low | 52.3% | Market Cap | $54.296b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |